This Article Full Text Free Full Text (PDF) Free All Versions of this Article: chest.06-2951v1 132/3/966    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Marthin, J. K. Articles by Nielsen, K. G. Search for Related Content PubMed PubMed Citation Articles by Marthin, J. K. Articles by Nielsen, K. G.

Pulmonary Radioaerosol Mucociliary Clearance in Diagnosis of Primary Ciliary Dyskinesia^*

^* From the Pediatric Pulmonary Service and Cystic Fibrosis Centre (Drs. Marthin, Pressler, and Nielsen), Department of Pediatrics, Clinic I, Juliane Marie Centre, and the Department of Clinical Physiology and Nuclear Medicine (Dr. Mortensen), Diagnostic Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Correspondence to: Kim Gjerum Nielsen, Dr Med Sci, Pediatric Pulmonary Service and Cystic Fibrosis Centre, Department of Pediatrics, Clinic I, Juliane Marie Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; e-mail: kgn{at}dadlnet.dk

Abstract

Background: Methods relying on nasal ciliary motility for the diagnosis of primary ciliary dyskinesia (PCD) are often hampered by secondary ciliary dyskinesia. A functional test for pulmonary mucociliary clearance, which is not influenced by secondary nasal ciliary defects, would be a valuable tool in a PCD workup.

Methods: The diagnostic validity and repeatability of a pulmonary radioaerosol mucociliary clearance (PRMC) test for the diagnosis of PCD was assessed in the following three sequentially performed substudies: (1) a preliminary cross-sectional study of PRMC in patients with known PCD; (2) a prospective blinded trial of patients referred for suspicion of PCD; and (3) an implementation study of PRMC as a routine method used in a PCD workup. PRMC was studied after ^99mTc-albumin colloid aerosol inhalation, and the results were compared to (1) the results of nasal ciliary motility studies, (2) ciliary ultrastructure, and (3) the final clinical diagnosis. The repeatability of PRMC was assessed in 14 patients.

Results: A total of 95 patients, 5 to 74 years of age, were included in the study (57 patients in whom PCD was diagnosed, 26 non-PCD patients, and 12 patients referred for PCD workup without a conclusive workup result). In substudy 1, 14 of 15 patients with known PCD showed impaired PRMC; the results were inconclusive in 1 patient. In substudy 2, among 59 patients referred for PCD workup PRMC test results, compared to nasal ciliary motility, showed a sensitivity of 88% and a specificity of 100%. In substudy 3, among 21 patients referred for PCD investigation who were included in a routine PCD workup after PRMC implementation, 71% of PRMC test results were in alignment with nasal ciliary motility. Repeatability of interpretation was seen in 13 of 14 cases. A conclusive PRMC after only one test was found in 81 of 95 patients (85%).

Conclusion: PRMC is a noninvasive functional test for total tracheobronchial mucociliary clearance with a high sensitivity and specificity for PCD, a high rate of conclusive results after only one test and a further ability to separate PCD from focal pulmonary mucociliary defects.

Key Words: mucociliary clearance • primary ciliary dyskinesia • secondary ciliary dyskinesia • ^99mTc-albumin colloid • tracheobronchial transport